Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Xu, Hua-Zhen  [Clear All Filters]
2023
Li Q-R, Xu H-Z, Xiao R-C, Liu B, Ma T-Q, Yu T-T, Li L-G, Wang M-F, Zhao L, Chen X, et al. Laser-triggered intelligent drug delivery and anti-cancer photodynamic therapy using platelets as the vehicle. Platelets. 2023;34(1):2166677.
2022
Han N, Li L-G, Peng X-C, Ma Q-L, Yang Z-Y, Wang X-Y, Li J, Li Q-R, Yu T-T, Xu H-Z, et al. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy by inhibiting GPX4 and enhancing ROS. Eur J Pharmacol. 2022:174797.
Yu T-T, Peng X-C, Wang M-F, Han N, Xu H-Z, Li Q-R, Li L-G, Xu X, Ma Q-L, Liu B, et al. Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer. J Cancer Res Clin Oncol. 2022.
Yang X-X, Xu X, Wang M-F, Xu H-Z, Peng X-C, Han N, Yu T-T, Li L-G, Li Q-R, Chen X, et al. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin. J Nanobiotechnology. 2022;20(1):230.
Xu H-Z, Li T-F, Ma Y, Li K, Zhang Q, Xu Y-H, Zhang Y-C, Zhao L, Chen X. Targeted photodynamic therapy of glioblastoma mediated by platelets with photo-controlled release property. Biomaterials. 2022;290:121833.
2021
Ma Q-L, Shen M-O, Han N, Xu H-Z, Peng X-C, Li Q-R, Yu T-T, Li L-G, Xu X, Liu B, et al. Chlorin e6 mediated photodynamic therapy triggers resistance through ATM-related DNA damage response in lung cancer cells. Photodiagnosis Photodyn Ther. 2021:102645.
Li T-F, Xu H-Z, Xu Y-H, Yu T-T, Tang J-M, Li K, Wang C, Peng X-C, Li Q-R, Sang X-Y, et al. Efficient Delivery of Chlorin e6 by Polyglycerol-Coated Iron Oxide Nanoparticles with Conjugated Doxorubicin for Enhanced Photodynamic Therapy of Melanoma. Mol Pharm. 2021.
Yu T-T, Sang X-Y, Han N, Peng X-C, Li Q-R, Xu X, Xiao R-C, Xu H-Z, Chen X, Wang M-F, et al. Macrophages mediated delivery of chlorin e6 and treatment of lung cancer by photodynamic reprogramming. Int Immunopharmacol. 2021;100:108164.